Daily Alpha · X
· Midday Alpha · by Buzzberg Research
X focused on the Marvell-Lumentum deal math, Oracle's capital raise and whether record de-grossing marks a bottom.
Themes on this desk
Marvell-Lumentum
Marvell-Lumentum premium collapses with Marvell stock; Jukan reads Lumentum acceptance as AI-cycle doubt; a supply-chain post sees independent laser suppliers re-rated.
AI financing
Oracle's $20B equity-and-debt raise and Anthropic's $895B commitments sharpen leverage and dilution scrutiny.
Positioning
Record de-grossing and high short interest; Tom Lee sees a bottom while Good Alexander liquidates stocks and shorts the S&P.
Ticker heat
?
Top voices by smart followers and alpha score
Market Radar →Jukan reads Lumentum's acceptance as a signal of doubt in the AI cycle
Jukan argues the only way to interpret Lumentum's management accepting this deal is that they have no faith in the current AI cycle and think the market will collapse in two to three years.
The only way to interpret Lumentum’s management accepting this deal is that they have no faith in the current AI
The comment challenges the view that the transaction is a vote of confidence in AI demand.
Watch Lumentum's forward guidance and AI infrastructure orders as the next check on that view.
Source →Hedge-fund de-grossing is the largest in a decade, with AI short interest rising
Citing Morgan Stanley data, the post says recent hedge-fund de-grossing exceeded 2016, 2018, 2020, 2021 and 2022 episodes, while Goldman's prime desk saw about $20B of selling over two weeks versus $23B in July's entire unwind. Short interest rose across AAOI, CRWV, CIFR and other AI-linked names.
We've finally made it to November... holy crap October was brutal.
Extreme de-grossing plus high short interest can fuel violent squeezes, but also signals fragile positioning.
Watch Whether follow-through buying persists after midterms and whether short interest keeps rising.
Source →Marvell-Lumentum premium has shrunk from 23.9% to about 5% in Marvell stock
ParadisLabs calculates the 4.5 Marvell-share exchange ratio at Marvell's $196.40 close equals about $884 per Lumentum share, below Lumentum's undisturbed $914 price, after Marvell fell roughly 22%. The $102.5B equity value is now about $80B; Lumentum needs Marvell above roughly $203 to regain any premium.
$LITE shareholders should be annoyed... The 23.9% premium in the $MRVL deal is real on paper, but in dollars it's
The deal is now an arbitrage on Marvell's share price; LITE holders bear Marvell beta.
Watch MRVL trading above roughly $203, which ParadisLabs says is needed for LITE holders to see a premium over the undisturbed price.
Source →Good Alexander liquidates all stocks, holds silver and crypto, shorts S&P 500
Alexander Good says he fully liquidated all stock positions; his largest position is silver, followed by Monero and Bitcoin, and he holds a short position in the S&P 500. The disclosure is a concrete risk-off allocation rather than a directional equity thesis.
@Fiskantes no - fully liquidated all stocks.
The disclosure shows an investor holding no stock positions and expressing outright equity caution.
Watch Whether the S&P 500 falls further and whether silver, Monero and Bitcoin outperform.
Source →Oracle falls 5% after announcing $20B equity-and-debt raise for AI buildout
Oracle stock fell more than 5% after announcing plans to raise $20B through equity and debt issuances to fund its AI buildout. The stock is now down 54% from this year's high.
BREAKING: Oracle stock, $ORCL, falls over -5% after announcing plans to raise $20 billion through equity and debt issuances to
The equity and debt raise turns Oracle's AI buildout into a financing and dilution test for shareholders.
Watch Oracle bond pricing, rating actions, and whether equity issuance is upsized.
Source →